Literature DB >> 33570081

Acute kidney injury in patients with Covid-19 in a Brazilian ICU: incidence, predictors and in-hospital mortality.

Rafael Lessa da Costa1, Taíza Corrêa Sória1, Eliene Ferreira Salles1, Ana Venâncio Gerecht1, Maurício Faria Corvisier1, Márcia Adélia de Magalhães Menezes1, Carla da Silveira Ávila1, Eduardo Costa de Freitas Silva2, Sara Regina Neto Pereira2, Luiz Fernando Nogueira Simvoulidis1.   

Abstract

INTRODUCTION: There is little data in the literature on acute kidney injury (AKI) in Covid-19 cases, although relevant in clinical practice in the ICU, especially in Brazil. Our goal was to identify the incidence of AKI, predictive factors and impact on hospital mortality.
METHOD: Retrospective cohort of patients with Covid-19 admitted to the ICU. AKI was defined according to KDIGO criteria. Data was collected from electronic medical records between March 17 and April 26.
RESULTS: Of the 102 patients, 55.9% progressed with AKI, and the majority (66.7%) was classified as stage 3. Multivariate logistic regression showed age (RC 1.101; 95% CI 1.026 - 1.181; p = 0.0070), estimated glomerular filtration rate - eGFR (RC 1.127; 95% CI 1.022 - 1.243; p = 0.0170) and hypertension (RC 3.212; 95% CI 1.065 - 9.690; p = 0.0380) as independent predictors of AKI. Twenty-three patients died. In the group without kidney injury, there were 8.9% deaths, while in the group with AKI, 33.3% of patients died (RR 5.125; 95% CI 1.598 - 16.431; p = 0.0060). The average survival, in days, was higher in the group without AKI. Cox multivariate analysis showed age (RR 1.054; 95% CI 1.014 - 1.095; p = 0.0080) and severe acute respiratory distress syndrome (RR 8.953; 95% CI 1.128 - 71.048; p = 0.0380) as predictors of hospital mortality.
CONCLUSION: We found a high incidence of AKI; and as predictive factors for its occurrence: age, eGFR and hypertension. AKI was associated with higher hospital mortality.

Entities:  

Year:  2021        PMID: 33570081     DOI: 10.1590/2175-8239-JBN-2020-0144

Source DB:  PubMed          Journal:  J Bras Nefrol        ISSN: 0101-2800


  8 in total

1.  Forgotten guidewire: A case report.

Authors:  Paulo Inácio Alves Ramos Diniz; Juan Eduardo Rios Rodriguez; João Pedro Salgado Pio Oliveira; Mirella Cruz Lira; Renan Danilo Lima da Rocha; Priscilla Ribeiro Dos Santos Campelo; Juliana da Costa Matos; Leonardo Pessoa Cavalcante
Journal:  Ann Med Surg (Lond)       Date:  2022-06-02

Review 2.  The Role of Visual Abstracts in the Dissemination of Medical Research.

Authors:  Beverley C Millar; Michelle Lim
Journal:  Ulster Med J       Date:  2022-06-15

Review 3.  Gender and Ethnic Disparities of Acute Kidney Injury in COVID-19 Infected Patients: A Literature Review.

Authors:  Weihang He; Xiaoqiang Liu; Bing Hu; Dongshui Li; Luyao Chen; Yu Li; Ke Zhu; Yechao Tu; Situ Xiong; Gongxian Wang; Bin Fu
Journal:  Front Cell Infect Microbiol       Date:  2022-01-13       Impact factor: 5.293

Review 4.  Mechanisms of COVID-19-induced kidney injury and current pharmacotherapies.

Authors:  Wissam H Faour; Ali Choaib; Elio Issa; Francesca El Choueiry; Khodor Shbaklo; Maryline Alhajj; Ramy Touma Sawaya; Zeina Harhous; Eman Alefishat; Moni Nader
Journal:  Inflamm Res       Date:  2021-11-21       Impact factor: 4.575

5.  Acute Kidney Injury and Renal Replacement Therapy in COVID-19 Versus Other Respiratory Viruses: A Systematic Review and Meta-Analysis.

Authors:  A Cau; M P Cheng; Terry Lee; A Levin; T C Lee; D C Vinh; F Lamontagne; J Singer; K R Walley; S Murthy; D Patrick; O Rewa; B Winston; J Marshall; J Boyd; J A Russell
Journal:  Can J Kidney Health Dis       Date:  2021-10-30

Review 6.  Novel insights into NOD-like receptors in renal diseases.

Authors:  Juan Jin; Tao-Jie Zhou; Gui-Ling Ren; Liang Cai; Xiao-Ming Meng
Journal:  Acta Pharmacol Sin       Date:  2022-04-01       Impact factor: 7.169

7.  Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial.

Authors:  Paulo Roberto Slud Brofman; Alejandro Correa; Carmen Lúcia Kuniyoshi Rebelatto; Alexandra Cristina Senegaglia; Claudio Luciano Franck; Debora Regina Daga; Patrícia Shigunov; Marco Augusto Stimamiglio; Daniela Boscaro Marsaro; Bruna Schaidt; Andressa Micosky; Ana Paula de Azambuja; Cleverson Alex Leitão; Ricardo Rasmussen Petterle; Valderez Ravaglio Jamur; Isadora May Vaz; Antônio Paulo Mallmann; Hipólito Carraro Junior; Eduardo Ditzel
Journal:  Stem Cell Res Ther       Date:  2022-03-21       Impact factor: 6.832

Review 8.  Acute kidney injury and electrolyte disorders in COVID-19.

Authors:  Gabriel Martins Nogueira; Noel Lucas Oliveira Rodrigues Silva; Ana Flávia Moura; Marcelo Augusto Duarte Silveira; José A Moura-Neto
Journal:  World J Virol       Date:  2022-09-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.